Literature DB >> 16314479

Membrane tumor necrosis factor confers partial protection to Listeria infection.

David Torres1, Laure Janot, Valerie F J Quesniaux, Sergei I Grivennikov, Isabelle Maillet, Jonathon D Sedgwick, Bernhard Ryffel, Francois Erard.   

Abstract

Tumor necrosis factor (TNF) plays a critical role in the host response to the intracellular pathogen Listeria monocytogenes (LM). TNF exists in soluble and membrane-bound forms and exhibits both unique and overlapping activities. We examined the role of membrane TNF in the absence of secreted TNF for host resistance in knockin mice in which the endogenous TNF was replaced by a regulated, noncleavable allele (mem-TNF). Macrophages expressing mem-TNF produced nitric oxide and displayed normal bactericidal activity. Although mice completely deficient in TNF (TNF(-/-)) succumbed to LM infection within 4 days, mem-TNF mice controlled LM infection at a low dose (10(4) CFU) but succumbed at a higher dose of infection (10(5) CFU). In contrast to complete TNF deficiency, mem-TNF mice developed confined microabscesses that expressed inducible nitric oxide synthase. The transfer of lymphocytes from immunized mem-TNF, but not TNF(-/-), mice protected TNF(-/-) mice from fatal infection. Taken together the data suggest that in the absence of soluble TNF, the presence of membrane-expressed TNF on phagocytes and lymphocytes partially restores host defense to LM infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314479      PMCID: PMC1613203          DOI: 10.1016/S0002-9440(10)61250-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  Infectious complications of biologic treatments of rheumatoid arthritis.

Authors:  Aparna K Mohan; Timothy R Coté; Jeffrey N Siegel; M Miles Braun
Journal:  Curr Opin Rheumatol       Date:  2003-05       Impact factor: 5.006

2.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

3.  Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.

Authors:  Maria L Olleros; Reto Guler; Nadia Corazza; Dominique Vesin; Hans-Pietro Eugster; Gilles Marchal; Pierre Chavarot; Christoph Mueller; Irene Garcia
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

4.  Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain.

Authors:  Craig A Murphy; Robert M Hoek; Maria T Wiekowski; Sergio A Lira; Jonathon D Sedgwick
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

5.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

6.  Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2.

Authors:  I Garcia; R Guler; D Vesin; M L Olleros; P Vassalli; Y Chvatchko; M Jacobs; B Ryffel
Journal:  Lab Invest       Date:  2000-09       Impact factor: 5.662

7.  Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation.

Authors:  S R Ruuls; R M Hoek; V N Ngo; T McNeil; L A Lucian; M J Janatpour; H Körner; H Scheerens; E M Hessel; J G Cyster; L M McEvoy; J D Sedgwick
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

8.  Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent.

Authors:  L G Bekker; A L Moreira; A Bergtold; S Freeman; B Ryffel; G Kaplan
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells.

Authors:  S Harashima; T Horiuchi; N Hatta; C Morita; M Higuchi; T Sawabe; H Tsukamoto; T Tahira; K Hayashi; S Fujita; Y Niho
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

10.  Cutting edge: antilisterial activity of CD8+ T cells derived from TNF-deficient and TNF/perforin double-deficient mice.

Authors:  D W White; V P Badovinac; G Kollias; J T Harty
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

View more
  23 in total

1.  Targeting ADAM17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial sepsis.

Authors:  Hemant K Mishra; Timothy J Johnson; Davis M Seelig; Bruce Walcheck
Journal:  J Leukoc Biol       Date:  2016-04-08       Impact factor: 4.962

2.  iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS.

Authors:  David R McIlwain; Philipp A Lang; Thorsten Maretzky; Koichi Hamada; Kazuhito Ohishi; Sathish Kumar Maney; Thorsten Berger; Aditya Murthy; Gordon Duncan; Haifeng C Xu; Karl S Lang; Dieter Häussinger; Andrew Wakeham; Annick Itie-Youten; Rama Khokha; Pamela S Ohashi; Carl P Blobel; Tak W Mak
Journal:  Science       Date:  2012-01-13       Impact factor: 47.728

3.  TNF deficiency dysregulates inflammatory cytokine production, leading to lung pathology and death during respiratory poxvirus infection.

Authors:  Ma Junaliah Tuazon Kels; Esther Ng; Zahrah Al Rumaih; Pratikshya Pandey; Sigrid R Ruuls; Heinrich Korner; Timothy P Newsome; Geeta Chaudhri; Gunasegaran Karupiah
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

Review 4.  TNF activity and T cells.

Authors:  Amit K Mehta; Donald T Gracias; Michael Croft
Journal:  Cytokine       Date:  2016-08-13       Impact factor: 3.861

5.  Period of irreversible therapeutic intervention during sepsis correlates with phase of innate immune dysfunction.

Authors:  David M Cauvi; Donghuan Song; Daniel E Vazquez; Dennis Hawisher; Jose A Bermudez; Michael R Williams; Stephen Bickler; Raul Coimbra; Antonio De Maio
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

Review 6.  Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.

Authors:  Takahiko Horiuchi; Hiroki Mitoma; Shin-ichi Harashima; Hiroshi Tsukamoto; Terufumi Shimoda
Journal:  Rheumatology (Oxford)       Date:  2010-03-01       Impact factor: 7.580

7.  Type I interferons regulate susceptibility to inflammation-induced preterm birth.

Authors:  Monica Cappelletti; Pietro Presicce; Matthew J Lawson; Vandana Chaturvedi; Traci E Stankiewicz; Simone Vanoni; Isaac Tw Harley; Jaclyn W McAlees; Daniel A Giles; Maria E Moreno-Fernandez; Cesar M Rueda; Paranth Senthamaraikannan; Xiaofei Sun; Rebekah Karns; Kasper Hoebe; Edith M Janssen; Christopher L Karp; David A Hildeman; Simon P Hogan; Suhas G Kallapur; Claire A Chougnet; Sing Sing Way; Senad Divanovic
Journal:  JCI Insight       Date:  2017-03-09

Review 8.  Monocytes and infection: modulator, messenger and effector.

Authors:  Huizhong Xiong; Eric G Pamer
Journal:  Immunobiology       Date:  2014-08-19       Impact factor: 3.144

9.  Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia.

Authors:  Pernille M Madsen; Bettina H Clausen; Matilda Degn; Stine Thyssen; Lotte K Kristensen; Martina Svensson; Nicholas Ditzel; Bente Finsen; Tomas Deierborg; Roberta Brambilla; Kate L Lambertsen
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-19       Impact factor: 6.200

10.  Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection.

Authors:  Nasiema Allie; Lena Alexopoulou; Valerie J F Quesniaux; Lizette Fick; Ksanthi Kranidioti; George Kollias; Bernhard Ryffel; Muazzam Jacobs
Journal:  Immunology       Date:  2008-06-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.